Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Hao Wang, Qiaohua Xie, Cong Cheng, Peng Wang, Liping Lei, ShouZi Hu, Guofang Liu, Huabang Zhou, YouShun Liu, Heping Hu
Publikováno v:
Bulletin du Cancer. 108:931-939
Summary Background Both modified Child-Pugh (MCP) and Albumin-bilirubin (ALBI) grade were reported that simpler, more objective and evidence-based alternative to the Child-Pugh (CP) class for assessing liver function. Aims To investigate whether the
Autor:
Zhen Zhou, Weimin Wang, Jianliang Deng, Tengyang Ni, Zewen Chu, Mengying Lv, Yanqing Liu, Yan Zhou
Publikováno v:
Bulletin du cancer. 109(3)
Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Despite great advances in medical technology, the survival rate of CRC patients is still extremely low, mainly due to recurrence and chemotherapy resistance. Therefore,
Publikováno v:
Bulletin du cancer. 108(12)
Summary Background Oral cancer is the twelfth largest malignant tumor in the world. Oral cancer is prone to lymph node metastasis in the early stages of the disease, and lymph node metastasis will directly affect the treatment and survival rate. Ther
Autor:
Jocelyn Gal, Michel Poudenx, Linda Bouhlel, Paul Hofman, Marius Ilie, Joël Guigay, Jérôme Doyen, Charles-Hugo Marquette, Jonathan Benzaquen, Josiane Otto, Emmanuel Chamorey, Jérôme Mouroux, Bernard Padovani, Renaud Schiappa, Jean-Philippe Berthet
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.946-958. ⟨10.1016/j.bulcan.2020.04.019⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.946-958. ⟨10.1016/j.bulcan.2020.04.019⟩
Summary It has been found that occurrence of immune-related adverse events (irAEs) is associated with outcome in the treatment of advanced non-small-cell lung cancer (NSCLC) with anti-programmed cell death (PD)-1 or anti-PDL1 agents. Independent corr
Autor:
Marwan Ghosn, Elie El Rassy, Joseph Kattan, Fadi Farhat, Tony Ibrahim, Colette Hanna, Abir Ahmadie, Fadi El Karak
Publikováno v:
Bulletin du cancer. 107(4)
Tumor profiling has been shown to benefit patients with rare or refractory metastatic cancer, but several limitations hamper its use in daily clinical practice. We aim to assess the added benefit of a comprehensive tumor profiling, including factors
Autor:
C. Dayen, Lionel Falchero, Olivier Molinier, Chrystele Locher, Michel Grivaux, Bernard Asselain, Cécile Dujon, Bertrand Delclaux, Didier Debieuvre
Publikováno v:
Bulletin du cancer. 106(4)
Although improved during the last decades, the prognosis of lung cancer is poor. In 2000, the French College of general hospital respiratory physicians, conducted KBP-2000-CPHG, a prospective multicenter epidemiological study including all volunteer
Autor:
Didier Debieuvre, Christine Mouroux-Rotomondo, Bernard Duvert, Michel Grivaux, Eric Goarant, Bernard Borrel, Camille Genety, Ghassan-Jacques Kassem, Gislaine Fraboulet, Jacques Piquet, Daniel Sandron
Publikováno v:
Bulletin du cancer. 104(10)
Summary Objective Increased postoperative mortality in low volume centers has contributed to merge and space thoracic surgical centers. Some studies have showed that the likelihood of receiving surgery was lower in lung cancer patients living far fro